Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
- 1 November 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 352 (9142), 1731-1738
- https://doi.org/10.1016/s0140-6736(98)04058-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemiaLeukemia, 1999
- Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual diseaseLeukemia, 1997
- Information booklet for parents of children surviving cancerLeukemia, 1997
- Monitoring minimal residual disease in peripheral blood in B‐lineage acute lymphoblastic leukaemiaBritish Journal of Haematology, 1997
- Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1997
- Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised childrenThe Lancet, 1996
- Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of inductionThe Lancet, 1994
- Detection of minimal residual leukemia by the polymerase chain reaction: potential implications for therapyClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcomeBritish Journal of Haematology, 1991
- T-cell antigen receptor genes and T-cell recognitionNature, 1988